The Gold Standard is a workplace- based program that focuses on lowering the risk of cancer.
The Life Sciences Consortium (LSC) brings together oncology companies to accelerate discovery and development of new therapies for all cancer patients. Visit Website
Since September 2007 Judy O’Hagan has been a Vice President of Sanofi U.S., where her scope of responsibilities include North America Pharmaceuticals, Global Services, Consumer Health Care, and R&D. At Sanofi, Judy serves as the Steering Committee Chairperson for WISE (Women Inspiring Sanofi Excellence) and is a member of the 2012 Healthcare Businesswomen’s Association (HBA) Advisory Board. Judy also serves as the Chairperson of the Cancer Gold Standard Task Force for the CEO Roundtable on Cancer. In her community, Judy serves on the Board of Jersey Battered Women’s Services and as a liaison to the Cristo Rey Network in Newark, New Jersey
Judy began her career in the pharmaceutical industry in 1978 as an HR professional at Sandoz Pharmaceuticals Corporation, and in 1996, when Sandoz and Ciba‐Geigy merged to form Novartis Pharmaceuticals, Judy was appointed Executive Director for the Organization and Leadership Development function. In 1999, Judy was appointed Vice President, Human Resources for the Commercial Division of Novartis.
Judy received her BA in French from Marquette University in Milwaukee, Wisconsin. She graduated Summa Cum Laude and Phi Beta Kappa.